GBG Forschungs GmbH (German Breast Group)
Industry / private company
Location:
Neu-Isenburg,
Germany (DE)
ISNI: 0000000404572954
ROR: https://ror.org/03c8hnh70
Show on Map:
Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer (2011)
Von Minckwitz G, Schweller K, Schmidt M, Barinoff J, Mundhenke C, Cufer T, Maartense E, et al.
Journal article
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial (2010)
Witzel I, Loibl S, Von Minckwitz G, Mundhenke C, Huober J, Hanusch C, Henschen S, et al.
Journal article